COLL

NASDAQ 已收盘

Collegium Pharmaceutical

25.21 USD
▼-0.72-2.78%
盘后 25.44 +0.91%
2026-11-19
市值
$768.18M
市盈率
21.83
EPS
1.13
股息率
—
52 周区间
21.43 – 50.79
成交量
445.96K
Beta
0.73
目标价
44.00
52W 低 21.4352W 高 50.79
价格走势

公司简介

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company’s portfolio includes Jornay PM, a central nervous system stimulant prescription medicine that contains methylphenidate HCl for the treatment of attention deficit hyperactivity disorder; Belbuca, a buccal film that contains buprenorphine for severe and persistent pain that requires an extended treatment period; Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxyco...